NanoGroup S.A. (WSE:NNG)

Market Cap	85.58M
Revenue (ttm)	100.00
Net Income (ttm)	-5.69M
Shares Out	31.64M
EPS (ttm)	-0.16
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,178
Average Volume	23,973
Open	2.635
Previous Close	2.705
Day's Range	2.630 - 2.710
52-Week Range	2.060 - 4.340
Beta	0.79
RSI	47.91
Earnings Date	Sep 19, 2025

About NanoGroup

NanoGroup S.A. operates as a biotechnology company in Poland. The company develops and licenses early-stage pre-clinical and IND solutions to international biotech and pharma companies. It also manages a portfolio of companies that manages projects for the need of modern medicine in the field of oncology and transplantology. The company was incorporated in 2016 and is based in Warsaw, Poland.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2016
• Country: Poland
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: NNG

Financial Performance

In 2024, NanoGroup's revenue was 2,100, an increase of 4.01% compared to the previous year's 2,019. Losses were -5.17 million, -34.50% less than in 2023.